In vivo and in vitro estrogenic and progestagenic actions of Tibolone

Keyphrases

• Tibolone 100%
• Estrogenic 100%
• Breast 30%
• Estrogen 30%
• Tissue Factor 30%
• Breast Cancer 20%
• Transvaginal Sonography 20%
• Endometrial Cancer 20%
• Progesterone 20%
• Bcl-xL 20%
• Adverse Effects 10%
• Breast Cancer Cells 10%
• Protein Level 10%
• Steroid Hormones 10%
• MCF-7 10%
• Ishikawa 10%
• Endometrial Cells 10%
• Hormone Replacement Therapy 10%
• In Vitro Model 10%
• Proliferative Phase 10%
• Oncogene 10%
• Postmenopausal Women 10%
• Cancer-associated Proteins 10%
• Million Women Study 10%
• Secretory Activity 10%
• Phenotype Characteristics 10%
• Thin Endometrium 10%
• Progestin 10%
• Patient Monitoring 10%
• Endometrial Cancer Risk 10%
• Unopposed Estrogen 10%

Medicine and Dentistry

• Tibolone 100%
• In Vitro 100%
• Breast Cancer 30%
• Uterine Cancer 30%
• Thromboplastin 30%
• Vaginal Ultrasonography 20%
• Epidermal Growth Factor Receptor 20%
• Progesterone 20%
• Bcl-xL 20%
• Selective Estrogen Receptor Modulator 20%
• Malignant Neoplasm 10%
• Alertness 10%
• Postmenopause 10%
• Endometrium 10%
• Steroid Hormone 10%
• Cancer Cell 10%
• Side Effect 10%
• Cancer Risk 10%
• Hormone Substitution 10%
• Gestagen 10%
• Oncogene 10%
• Patient Monitoring 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Tibolone 100%
• Breast Cancer 30%
• Thromboplastin 30%
• Endometrium Cancer 30%
• Epidermal Growth Factor Receptor 20%
• Progesterone 20%
• Selective Estrogen Receptor Modulator 20%
• Replacement Therapy 10%
• Malignant Neoplasm 10%
• Side Effect 10%
• Steroid Hormone 10%
• Progestin 10%